CD4 and plasma cell myeloma: In a myeloma model, BMSCs promoted MM cells, likely by suppressing CD4+ T cells via the PD-L1−PD-1 pathway, indicating that the anti-PD-1 antibody may inhibit BMSC-induced MM cell growth [78].